Prices are updated after-hours


Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date

symbols : GILD    save search

Humanigen Announces Peer-Reviewed Publication in Thorax Supporting Early Treatment of Hospitalized COVID-19 Patients with Lenzilumab Guided by C-Reactive Protein
Published: 2022-07-06 (Crawled : 13:00) - biospace.com/
HGEN | $0.0361 -61.5% 120M twitter stocktwits trandingview |
Health Technology
| | O: 0.0% H: 27.62% C: 14.36%
GILD | News | $66.16 -1.15% -1.16% 6.4M twitter stocktwits trandingview |
Health Technology
| | O: 0.72% H: 0.41% C: 0.18%

covid-19 treatment lenzilumab publication
BioNTech Completes Acquisition of Kite’s Neoantigen TCR Cell Therapy R&D Platform and Manufacturing Facility in Gaithersburg, Maryland
Published: 2021-08-04 (Crawled : 12:00) - biospace.com/
SNY | News | $45.395 -1.55% -1.58% 4.4M twitter stocktwits trandingview |
Health Technology
| | O: -1.98% H: 0.73% C: -1.19%
GILD | News | $66.16 -1.15% -1.16% 6.4M twitter stocktwits trandingview |
Health Technology
| | O: -0.49% H: 0.72% C: -0.36%
BNTX | $86.19 -0.24% -0.24% 580K twitter stocktwits trandingview |
Health Technology
| | O: 2.61% H: 20.19% C: 14.8%

acquisition therapy
Global CAR T-Cell Therapy Market Analysis Report 2023: Drug type, Indication, Target Antigen, End-user and Region - Forecast to 2030
Published: 2024-01-24 (Crawled : 17:00) - prnewswire.com
PFE A | $25.39 -0.12% -0.12% 36M twitter stocktwits trandingview |
Health Technology
| | O: 0.39% H: 0.82% C: -0.74%
NVS | $92.57 -0.55% 0.0% 910K twitter stocktwits trandingview |
Health Technology
| | O: 0.22% H: 0.43% C: -0.39%
SRNE | $0.028 -8.85% 42K twitter stocktwits trandingview |
Health Technology
| | O: -63.33% H: 263.64% C: 127.27%
GILD | News | $66.16 -1.15% -1.16% 6.4M twitter stocktwits trandingview |
Health Technology
| | O: 0.1% H: 0.43% C: -0.04%
AUTL | $4.8 -0.83% -0.83% 1.2M twitter stocktwits trandingview |
Health Technology
| | O: -0.91% H: 11.52% C: 4.94%

drug report t-cell global therapy market
HOOKIPA Reports Fourth Quarter and Full Year 2020 Financial Results and Provides 2021 Outlook
Published: 2021-03-18 (Crawled : 12:00) - globenewswire.com
HOOK | $0.7695 0.92% 0.91% 170K twitter stocktwits trandingview |
Health Technology
| | O: 0.08% H: 9.84% C: 6.32%
GILD | News | $66.16 -1.15% -1.16% 6.4M twitter stocktwits trandingview |
Health Technology
| | O: -1.24% H: 2.14% C: 0.72%

financial results results
Arcellx and Kite Announce Strategic Collaboration to Co-Develop and Co-Commercialize Late-Stage Clinical CART-ddBCMA in Multiple Myeloma
Published: 2022-12-09 (Crawled : 14:00) - biospace.com/
ACLX | $54.5 1.77% 1.74% 600K twitter stocktwits trandingview |
| | O: 20.66% H: 9.21% C: 7.11%
GILD | News | $66.16 -1.15% -1.16% 6.4M twitter stocktwits trandingview |
Health Technology
| | O: -0.23% H: 0.0% C: -1.45%

collaboration
HOOKIPA Pharma Reports Third Quarter 2023 Financial Results and Recent Business Highlights
Published: 2023-11-09 (Crawled : 12:00) - globenewswire.com
HOOK | $0.7695 0.92% 0.91% 170K twitter stocktwits trandingview |
Health Technology
| | O: -7.94% H: 8.7% C: -4.37%
GILD | News | $66.16 -1.15% -1.16% 6.4M twitter stocktwits trandingview |
Health Technology
| | O: -0.47% H: 0.23% C: -3.29%

pharma business financial
IGM Biosciences Announces Second Quarter 2021 Financial Results and Provides Corporate Update
Published: 2021-08-09 (Crawled : 21:00) - igmbio.com
IGMS | $7.4 -8.98% -9.86% 450K twitter stocktwits trandingview |
Health Technology
| | O: 0.51% H: 7.28% C: 5.3%
GILD | News | $66.16 -1.15% -1.16% 6.4M twitter stocktwits trandingview |
Health Technology
| | O: 0.0% H: 0.71% C: -0.47%

financial results results bioscience
Cellular Immunotherapy Market Research Report by Type, Indication, Technology Type, End Use, Region - Global Forecast to 2027 - Cumulative Impact of COVID-19
Published: 2022-11-10 (Crawled : 17:00) - prnewswire.com
GLAXF | $20.2 -14.18% 510 twitter stocktwits trandingview |
Health Technology
| | O: -0.06% H: 0.0% C: 0.0%
AZNCF | $140.15 -4.19% 560 twitter stocktwits trandingview |
Health Technology
| | O: 6.22% H: 3.13% C: -0.56%
NVS | $92.57 -0.55% 0.0% 910K twitter stocktwits trandingview |
Health Technology
| | O: 2.81% H: 0.43% C: -0.2%
JNJ | News | $145.74 0.67% 0.0% 9.3M twitter stocktwits trandingview |
Health Technology
| | O: 0.18% H: 0.0% C: 0.0%
GSK | $39.27 -0.83% 0.01% 2.2M twitter stocktwits trandingview |
Health Technology
| | O: 2.59% H: 0.72% C: 0.63%
BMY | $48.3 0.96% -0.1% 11M twitter stocktwits trandingview |
Health Technology
| | O: 1.22% H: 0.01% C: -1.7%
IOVA M | $11.72 -0.68% -0.68% 3.6M twitter stocktwits trandingview |
Health Technology
| | O: 6.12% H: 4.99% C: 4.21%
INO 3 d | $10.22 -7.68% -8.32% 400K twitter stocktwits trandingview |
Health Technology
| | O: 5.5% H: 4.35% C: 3.48%
GILD | News | $66.16 -1.15% -1.16% 6.4M twitter stocktwits trandingview |
Health Technology
| | O: 1.43% H: 0.36% C: -1.08%
ATRA | $0.6917 -3.25% -3.35% 830K twitter stocktwits trandingview |
Health Technology
| | O: 2.58% H: 23.12% C: 20.85%
AZN | $68.36 -0.25% -0.25% 4M twitter stocktwits trandingview |
Health Technology
| | O: 7.08% H: 0.84% C: -0.43%
ADAP | $0.8984 -8.98% -9.86% 3.3M twitter stocktwits trandingview |
Health Technology
| | O: 0.0% H: 7.14% C: 5.71%

covid-19 research global immunotherapy report impact technology market
Reviews of Pediatric Studies Conducted under BPCA and PREA from 2012 – present
Published: 2021-03-25 (Crawled : 15:49) - fda.gov
PFE A | $25.39 -0.12% -0.12% 36M twitter stocktwits trandingview |
Health Technology
| | O: 0.11% H: 0.39% C: 0.06%
LLY | $745.95 -0.64% -0.1% 1.7M twitter stocktwits trandingview |
Health Technology
| | O: 0.46% H: 1.46% C: 1.15%
BMY | $48.3 0.96% -0.1% 11M twitter stocktwits trandingview |
Health Technology
| | O: 1.12% H: 0.0% C: -0.33%
ABBV | News | $164.66 0.25% -0.15% 4.5M twitter stocktwits trandingview |
Health Technology
| | O: -0.16% H: 1.21% C: 0.95%
SUPN | $28.88 -0.41% -0.42% 350K twitter stocktwits trandingview |
Health Technology
| | O: -0.32% H: 5.23% C: 4.43%
SNY | News | $45.395 -1.55% -1.58% 4.4M twitter stocktwits trandingview |
Health Technology
| | O: 0.89% H: 0.5% C: 0.41%
OTIC | $0.077 twitter stocktwits trandingview |
Health Technology
| | O: -1.88% H: 2.3% C: 0.0%
OMER | $3.22 -3.59% -3.73% 430K twitter stocktwits trandingview |
Health Technology
| | O: -1.44% H: 3.5% C: 2.24%
GILD | News | $66.16 -1.15% -1.16% 6.4M twitter stocktwits trandingview |
Health Technology
| | O: 0.67% H: 0.15% C: -1.22%
BMRN S | $90.08 -0.43% -0.43% 940K twitter stocktwits trandingview |
Health Technology
| | O: -0.72% H: 1.06% C: 0.76%
BCRX | $4.49 -1.97% -2.0% 3M twitter stocktwits trandingview |
Health Technology
| | O: -4.08% H: 7.03% C: 6.04%
AMGN | $262.77 -0.49% -0.49% 2M twitter stocktwits trandingview |
Health Technology
| | O: 0.64% H: 0.2% C: -0.32%


Jounce Therapeutics Announces Pricing of $56.25 Million Public Offering of Common Stock
Published: 2021-03-10 (Crawled : 04:00) - globenewswire.com
JNCE | $1.88 -2.59% -1.85% 0 twitter stocktwits trandingview |
Health Technology
| | O: -5.07% H: 6.86% C: 4.81%
GILD | News | $66.16 -1.15% -1.16% 6.4M twitter stocktwits trandingview |
Health Technology
| | O: 0.54% H: 0.19% C: -1.19%

offering
HOOKIPA Pharma to Report Third Quarter 2021 Financial Results on Wednesday, November 10, 2021
Published: 2021-11-03 (Crawled : 13:00) - biospace.com/
HOOK | $0.7695 0.92% 0.91% 170K twitter stocktwits trandingview |
Health Technology
| | O: -0.4% H: 6.8% C: 6.0%
GILD | News | $66.16 -1.15% -1.16% 6.4M twitter stocktwits trandingview |
Health Technology
| | O: 0.27% H: 2.44% C: 2.21%

financial results results pharma
Aadi Bioscience Announces Closing of Merger with Aerpio Pharmaceuticals and $155M Private Placement
Published: 2021-08-26 (Crawled : 00:00) - globenewswire.com
JNJ | News | $145.74 0.67% 0.0% 9.3M twitter stocktwits trandingview |
Health Technology
| | O: 0.57% H: 0.0% C: 0.0%
GILD | News | $66.16 -1.15% -1.16% 6.4M twitter stocktwits trandingview |
Health Technology
| | O: -0.17% H: 1.6% C: -0.04%
FBIO | $1.81 2.26% 2.21% 440K twitter stocktwits trandingview |
Health Technology
| | O: 0.65% H: 5.79% C: 4.5%

merge bioscience
Galapagos announces full year 2022 results and outlook for 2023
Published: 2023-02-23 (Crawled : 22:00) - globenewswire.com
GILD | News | $66.16 -1.15% -1.16% 6.4M twitter stocktwits trandingview |
Health Technology
| | O: -0.33% H: 0.04% C: -1.96%
GLPG | $28.9 -1.1% -1.11% 140K twitter stocktwits trandingview |
Health Technology
| | O: -7.42% H: 5.64% C: 4.06%

year
Kadcyla Leads the Global Antibody Drug Conjugates Market with Extensive Use in Breast Cancer Treatment
Published: 2023-11-01 (Crawled : 18:00) - prnewswire.com
ALPMY | $9.46 -1.11% 500K twitter stocktwits trandingview |
Manufacturing
| | O: -1.46% H: 3.67% C: 3.26%
ZYME | $8.68 -1.92% -1.96% 730K twitter stocktwits trandingview |
Health Technology
| | O: 1.14% H: 0.42% C: -0.7%
TAK | News | $13.16 0.08% 0.0% 1.3M twitter stocktwits trandingview |
Health Technology
| | O: 1.03% H: 0.73% C: 0.58%
ADCT | $4.76 -4.03% 0.0% 280K twitter stocktwits trandingview |
Health Technology
| | O: -0.16% H: 6.42% C: 4.49%
ABBV | News | $164.66 0.25% -0.15% 4.5M twitter stocktwits trandingview |
Health Technology
| | O: -0.86% H: 0.0% C: 0.0%
STRO M | $3.76 -1.05% -1.06% 770K twitter stocktwits trandingview |
Health Technology
| | O: 0.39% H: 3.86% C: 3.86%
IMGN | $31.23 0.03% 49M twitter stocktwits trandingview |
Health Technology
| | O: 5.09% H: 5.48% C: -1.27%
GILD | News | $66.16 -1.15% -1.16% 6.4M twitter stocktwits trandingview |
Health Technology
| | O: -0.47% H: 1.88% C: 1.78%
EXEL | $22.47 -1.75% -1.78% 2.6M twitter stocktwits trandingview |
Health Technology
| | O: -2.62% H: 1.17% C: -1.66%

drug antibody breast cancer treatment global market
Francesco M. Marincola Joins Kite as Worldwide Head of Cell Therapy Research
Published: 2021-01-19 (Crawled : 15:00) - biospace.com/
GILD | News | $66.16 -1.15% -1.16% 6.4M twitter stocktwits trandingview |
Health Technology
| | O: 2.21% H: 5.29% C: 3.62%

therapy research
Global Rheumatology Therapeutics Market Research Report to 2027 - Featuring AbbVie, Amgen and Beckman Coulter Among Others
Published: 2022-04-26 (Crawled : 13:20) - prnewswire.com
SNYNF | News | $92.7 -2.18% 1.4K twitter stocktwits trandingview |
Health Technology
| | O: -1.81% H: 0.0% C: 0.0%
AZNCF | $140.15 -4.19% 560 twitter stocktwits trandingview |
Health Technology
| | O: 3.09% H: 0.0% C: -2.9%
UCBJY | $64.07 -4.38% 72K twitter stocktwits trandingview |
Manufacturing
| | O: -0.33% H: 0.0% C: -1.56%
TMO | News | $541.52 -1.05% 0.61% 2.1M twitter stocktwits trandingview |
Health Technology
| | O: -1.19% H: 0.0% C: 0.0%
TAK | News | $13.16 0.08% 0.0% 1.3M twitter stocktwits trandingview |
Health Technology
| | O: -0.48% H: 0.0% C: 0.0%
PFE A | $25.39 -0.12% -0.12% 36M twitter stocktwits trandingview |
Health Technology
| | O: 3.08% H: 0.0% C: 0.0%
JNJ | News | $145.74 0.67% 0.0% 9.3M twitter stocktwits trandingview |
Health Technology
| | O: 2.0% H: 0.0% C: 0.0%
LLY | $745.95 -0.64% -0.1% 1.7M twitter stocktwits trandingview |
Health Technology
| | O: 0.34% H: 1.41% C: -1.17%
BMY | $48.3 0.96% -0.1% 11M twitter stocktwits trandingview |
Health Technology
| | O: -0.09% H: 1.26% C: -0.51%
VRTX | News | $393.51 0.1% 0.1% 950K twitter stocktwits trandingview |
Health Technology
| | O: -0.22% H: 0.43% C: -1.25%
SNY | News | $45.395 -1.55% -1.58% 4.4M twitter stocktwits trandingview |
Health Technology
| | O: -0.11% H: 0.0% C: 0.0%
RIGL | $1.06 -4.51% -4.72% 1.2M twitter stocktwits trandingview |
Health Technology
| | O: -0.38% H: 4.92% C: -4.55%
REGN | $893.66 -0.84% -0.84% 450K twitter stocktwits trandingview |
Health Technology
| | O: -0.72% H: 0.0% C: 0.0%
GILD | News | $66.16 -1.15% -1.16% 6.4M twitter stocktwits trandingview |
Health Technology
| | O: -0.13% H: 0.0% C: 0.0%
AZN | $68.36 -0.25% -0.25% 4M twitter stocktwits trandingview |
Health Technology
| | O: -0.03% H: 0.53% C: -1.33%

research report therapeutics market
Reviews of Pediatric Studies Conducted under BPCA and PREA from 2012 – present
Published: 2021-06-21 (Crawled : 00:00) - fda.gov
PFE A | $25.39 -0.12% -0.12% 36M twitter stocktwits trandingview |
Health Technology
| | O: 0.18% H: 1.54% C: 1.39%
LLY | $745.95 -0.64% -0.1% 1.7M twitter stocktwits trandingview |
Health Technology
| | O: 0.25% H: 2.13% C: 1.63%
BMY | $48.3 0.96% -0.1% 11M twitter stocktwits trandingview |
Health Technology
| | O: 0.21% H: 0.83% C: 0.33%
ABBV | News | $164.66 0.25% -0.15% 4.5M twitter stocktwits trandingview |
Health Technology
| | O: 0.5% H: 1.37% C: 0.91%
XERS | $1.77 -0.56% -0.56% 1.1M twitter stocktwits trandingview |
Health Technology
| | O: 0.24% H: 0.73% C: -4.13%
SNY | News | $45.395 -1.55% -1.58% 4.4M twitter stocktwits trandingview |
Health Technology
| | O: -0.32% H: 0.17% C: -0.13%
OTIC | $0.077 twitter stocktwits trandingview |
Health Technology
| | O: 0.0% H: 3.98% C: -1.33%
OMER | $3.22 -3.59% -3.73% 430K twitter stocktwits trandingview |
Health Technology
| | O: 1.39% H: 0.79% C: 0.33%
GILD | News | $66.16 -1.15% -1.16% 6.4M twitter stocktwits trandingview |
Health Technology
| | O: 0.57% H: 0.86% C: 0.54%
BCRX | $4.49 -1.97% -2.0% 3M twitter stocktwits trandingview |
Health Technology
| | O: 0.5% H: 4.88% C: 4.7%
AMGN | $262.77 -0.49% -0.49% 2M twitter stocktwits trandingview |
Health Technology
| | O: 0.4% H: 0.53% C: 0.25%


Matinas BioPharma Announces Collaboration with the National Institute of Allergy and Infectious Diseases to Evaluate Oral Formulations of Gilead’s Antiviral Remdesivir Utilizing Matinas’ LNC Platform Delivery Technology
Published: 2020-12-07 (Crawled : 12:00) - globenewswire.com
GILD | News | $66.16 -1.15% -1.16% 6.4M twitter stocktwits trandingview |
Health Technology
| | O: 0.17% H: 0.06% C: -1.35%
MTNB | $0.19 -1.04% 0.0% 960K twitter stocktwits trandingview |
Health Technology
| | O: 10.09% H: 4.17% C: -7.5%

biopharma collaboration disease announces collaboration liver infectious disease antiviral
Kite and Oxford BioTherapeutics Establish Cell Therapy Research Collaboration in Blood Cancers and Solid Tumors
Published: 2021-01-06 (Crawled : 17:00) - biospace.com/
GILD | News | $66.16 -1.15% -1.16% 6.4M twitter stocktwits trandingview |
Health Technology
| | O: -0.5% H: 3.98% C: 3.77%

therapy collaboration cancer blood ford research solid tumors
Trodelvy® Significantly Improves Overall Survival in Pre-Treated HR+/HER2- Metastatic Breast Cancer Patients in the TROPiCS-02 Study
Published: 2022-08-15 (Crawled : 16:00) - biospace.com/
GILD | News | $66.16 -1.15% -1.16% 6.4M twitter stocktwits trandingview |
Health Technology
| | O: 1.41% H: 3.83% C: 3.7%

cs-02 trodelvy cancer study her2- her2 metastatic breast cancer
Gainers vs Losers
64% 36%

Top 10 Gainers
AGBA | News | $1.02 155.0% 57.94% 120M twitter stocktwits trandingview |
Finance

ZCMD | $2.86 108.76% 52.1% 2.3M twitter stocktwits trandingview |
Commercial Services

INVO | $1.555 104.6% 51.13% 5M twitter stocktwits trandingview |
Health Technology

ISPC | $0.437 105.16% 49.53% 37M twitter stocktwits trandingview |
Professional, Scientific, and T...

WLGS | News | $0.92 84.0% 45.65% 1.6M twitter stocktwits trandingview |

OST | $0.499 21.38% 45.26% 1.9M twitter stocktwits trandingview |

XPON | News | $3.1 60.62% 37.74% 17M twitter stocktwits trandingview |

TIRX | $0.7 44.39% 30.74% 58M twitter stocktwits trandingview |

BNTC | News | $6.92 44.17% 30.64% 3.5M twitter stocktwits trandingview |
Health Technology

GGE | $0.035 19.86% 29.3% 64M twitter stocktwits trandingview |


Your saved searches
Save your searches and get alerts when important news are released.